PUBLICATION

Structural analysis and biological effects of a neutral polysaccharide from the fruits of Rosa laevigata

Authors
Zhang, J., Song, Z., Li, Y., Zhang, S., Bao, J., Wang, H., Dong, C., Ohizumi, Y., Xu, J., Guo, Y.
ID
ZDB-PUB-210511-6
Date
2021
Source
Carbohydrate Polymers   265: 118080 (Journal)
Registered Authors
Keywords
2′, 7′-Dichlorofluorescein diacetate (PubChem CID: 104913), 3-Amino, 4-aminomethyl-2′, 7′-difluorescein diacetate (PubChem CID: 2762646), Antitumor activity, Chloroform (PubChem CID: 6212), Dimethyl sulfoxide (PubChem CID: 679), Immunoregulatory activity, Methyl iodide (PubChem CID: 6328), Neutral polysaccharide, Rosa laevigata, Sodium borohydride (PubChem CID: 4311764), Sodium chloride (PubChem CID: 5234), Thiazolyl blue tetrazolium bromide (PubChem CID: 64965), Tricaine (PubChem CID: 261501), Trifluoroacetic acid (PubChem CID: 6422), Zebrafish xenograft model
MeSH Terms
  • Animals
  • Antineoplastic Agents/pharmacology
  • Cell Movement/drug effects
  • Cell Proliferation/drug effects
  • Fruit/chemistry*
  • Humans
  • Immunologic Factors/pharmacology
  • Immunomodulation/drug effects
  • K562 Cells
  • Mice
  • Molecular Weight
  • Monosaccharides/analysis
  • Nitric Oxide/analysis
  • Polysaccharides/chemistry*
  • Polysaccharides/pharmacology*
  • RAW 264.7 Cells
  • Reactive Oxygen Species
  • Rosa/chemistry*
  • Zebrafish
PubMed
33966844 Full text @ Carbohydr. Polym.
Abstract
A neutral water-soluble polysaccharide (RLP50-2) was extracted and purified from the fruits of Rosa laevigata. The absolute molecular weight was determined as 1.26 × 104 g/mol. Monosaccharide composition analysis showed that RLP50-2 mainly consisted of glucose, arabinose, and galactose. Structural analysis revealed that RLP50-2 consisted of →5)-α-L-Araf-(1→, →2,5)-α-L-Araf-(1→, →3,5)-α-L-Araf-(1→, →4)-α-D-Glcp-(1→, →6)-α-D-Glcp-(1→, →3,6)-β-D-Glcp-(1→, →4)-α-D-Galp-(1→, →6)-β-D-Galp-(1→, →2)-β-D-Xylp-(1→, terminal α-L-arabinose, and terminal β-D-mannose. Biological assays showed that RLP50-2 had immunomodulatory activities using cell and zebrafish models. Moreover, RLP50-2 showed significantly antitumor activities by inhibiting tumor cell proliferation and migration and blocking angiogenesis. These results suggested that RLP50-2 could be developed as a potential immunomodulatory agent or antitumor candidate drug in biomedicine field.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping